Purchase Order 36C26126P0278

Edwards Lifesciences LLC has been awarded a firm fixed-price purchase order valued at $32,500 for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics restocking. The contract, awarded December 30, 2025, with an ultimate completion date of March 29, 2026, will be performed in San Francisco, California, and funded by Veterans Integrated Service Network 21, a component of the U.S. Department of Veterans Affairs. This award carries no set-aside designation and represents a continuation of Edwards Lifesciences' established role as a critical supplier of advanced cardiovascular medical devices to the VA system.

As a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, Edwards Lifesciences LLC specializes in providing specialized cardiac surgical implants and transcatheter heart valves to support veteran healthcare. This purchase order aligns with the company's existing relationship with the VA, which includes two significant indefinite delivery contracts valued at $2.5 million and $1.25 million respectively. The current award addresses the need to maintain adequate inventory of short shelf-life cardiac devices at VA facilities, enabling timely access to these critical surgical implants for veteran patients requiring TAVR procedures.